This experiment mainly optimizes Agaricus Blazei Polipeptide (ABP) extraction technology and evaluates the protection effect on aging mice. In this study, a new single component, M 3 KD, isolated and purified from Agaricus Blazei. The aging mouse model was established using D-galactose. After the ABP administration, the contents of total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (cat), and reactive oxygen species changed significantly. Through immunofluorescence staining, observed that ABP can reduce brain tissue changes. The expression of the generation of genes was analyzed by RNA-SEQ.
A total of 295 genes expressed differently filtered in the ABP Gen Group.rt-QPCR verify the important gene and show that the level of MRNA HSPH1, Trim32, HNRNPA1, and Grik5 expression increased significantly, and people from APOE, ATP1A3, STXBP1, and MAPK8IP1 decreased significantly. West Blotting shows that the level of expression of KAPE1 and P53 protein is significantly lower, while the level of protein expression of NRF2, HO-1, HSPH1, and TRIM32 is significantly higher in the ABP group.
ABP plays an anti-aging role in a rat aging model. Specific work mechanisms may be related to the expression regulations of the KAPE1 / NRF2 / P53 signaling path and related factors. Practical application: This research can contribute to the development of ABP as functional food or food supplements for anti-aging in the future.
Carboxyl-terminal polypeptide fragment from MUC16 Combing Stathmin1 promotes migration and bile cancer cell invasion
CA-125, encoded by Gen MUC16, is responsible for various types of tumor metastasis. However, related mechanisms are still unclear. We have set new ways to reveal gallbladder cancer metastasis related to the serum level CA-125 through C-terminal polypeptides from Gen16 production. MUC16 C-terminal polypeptides significantly promote bile cancer cell migration and in vitro invasion. The mass spectrum indicates that the interaction of MUC16 terminal C fragment with the C-STATHmin1 terminal domain inhibits STATHMIN1 phosphorylation to promote combinations with tubulins.
STATHMIN1 Knockdown Inhibits migration and invasion of bile cancer cells in vitro and metastasis in vivo lungs caused by polypeptides Terminal C-terminal MUC16. The level of high expression of MUC16C is consistent with STATHMIN1 is also confirmed in the gallbladder cancer tissue. Our study revealed the mechanism that underlies the gallbladder cancer metastasis related to the level of CA-125, which is useful for CA-125 in the diagnosis and therapy of gallbladder cancer.
Localization of vasoactive polypeptide receptor 1 (VPAC1) in neuroendocrine hypothalamic neuroendocrine neurons; Potential role in circadian prolactin secretion
Prolactin (PRL) is a versatile hormone and presents various physiological functions other than lactation. The release of the PRL from lactotrof in the hypophysis owned in mice is proven to be released with a circadian pattern depending on the physiological state of the animal. The release of the Circadian PRL seems to be a complex involving tonic inhibition by dopamine (DA) neurons in lactotrof and one or even several release factors. Because of the pattern of release of circadian PRL, neurons in the suprachiasmatic nucleus (SCN), “brain clock,” and especially neurons that express neuropeptide vasoactive polypeptide intestine (VIP), have been advised to be involved in the circadian regulation.

In this study, we use immunohistochemical fluorescence, in hybridization histochemistry situ, confocal microscope, three-dimensional reconstruction, and very specific antibodies to visualize the occurrence of VIP 1 and 2 receptors (VPAC1 and VPAC2) in the stained mouse hypothalamic section in combination with VIP , Oxytocin (OXT), Arginine Vasopresin (AVP), and DA (Tyrosine hydroxylase, th). We show that VIP fiber is likely to come from the ventral part of the SCN project to OXT neurons in the magnocelluler part of nucleus paraventricular (PVN).
In PVN, VIP fibers found in the application close to Oxt Neurons exclusively express VPAC1 receptors. Next, we show that Oxt neurons or AVP neurons do not express VPAC2 receptors. The expression of VPAC receptors is also found in blood vessels but not in neurons that express AVP or th. These findings indicate that VIP signaling from the SCN does not directly target neurons involved in the PLL secretion. Furthermore, the findings support the idea that the VIP from neurons in the SCN can regulate the release of circadian oxt in pituitary neurons or posterior modulation as the release factor involved in the temperature regulation of lactotrof.
Pancreas polypeptides but not other members of the Neuropeptide Y family show a moderate relationship with anxiety felt in a fat man
Neuropeptide Y (NPY), Peptide Tyrosine Tyrosine (PYY), and Pancreatic Polypeptide (PP) is an important mediator in two-way communication along the intestinal axis. Most famous for their role in taste rules and their food intake is considered to play an important role in the development of obesity. In addition, evidence of installation shows regulatory functions in anxiety, mood and stress resistance with gender potential differences. In this study, we examined the association of NPY, PYY, and PP plasma levels with anxiety, depression and stress felt in obesity patients.
We analyzed 144 inpatients (90 women, 54 men, BMI: 49.4 kg / m2) in naturalistic care settings for obesity and somatic and mental comorbidity. Fasting blood samples were taken, and the patient completed the psychometric self-assessment questionnaire (GAD-7, PHQ-9, PSQ-20) in the first week after entering and before exiting. The plasma concentration of peptides was measured by Elisa. Women showed higher anxiety (GAD-7: 8.13 ± 5.67 vs 5.93 ± 5.42, p = 0.04) and stress scores (PSQ-20: 52.62 ± 23.5 vs 41.23 ± 0.01 ) than men. In the longitudinal analysis of women with increasing clinically relevant anxiety (≥ 5 points at GAD-7, P <0.001) also showed a significant increase in depression (PHQ-9: 38%, p = 0.002) and PSQ-20 score (23) %, p = 0.005) while male patients who enhanced anxiety only increased in the tension of the PSQ-20 subscale (34%, p = 0.02).
In the man we observed the positive correlation of PP with anxiety scores (GAD-7: R = 0.41, p = 0.007) and with age (r = 0.49, p = 0.001) when entered while NPY correlated negatively with age (r = -0.38), p = 0.01). Instead, there was no significant association (P> 0.05) on the subject of women in cross-sectional and in longitudinal analysis. In conclusion, women who suffer from terrible obesity show greater psychological comorbidity and considerable interaction between them.
PTCHD2 Antibody |
4925-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4925-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
24792-100ul |
SAB |
100ul |
EUR 468 |
PTCHD2 Antibody |
24797-100ul |
SAB |
100ul |
EUR 468 |
PTCHD2 Antibody |
25404-100ul |
SAB |
100ul |
EUR 468 |
Polyclonal PTCHD2 Antibody |
AMR09590G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09591G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09592G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Human PTCHD2 shRNA Plasmid |
20-abx961520 |
Abbexa |
|
|
|
Polyclonal PTCHD2 Antibody (N-Terminus) |
AMR09593G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 (N-Terminus). This antibody is tested and proven to work in the following applications: |
Ptchd2 ORF Vector (Mouse) (pORF) |
ORF055152 |
ABM |
1.0 ug DNA |
EUR 1886.4 |
PTCHD2 ORF Vector (Human) (pORF) |
ORF028512 |
ABM |
1.0 ug DNA |
Ask for price |
Ptchd2 sgRNA CRISPR Lentivector set (Mouse) |
K3185201 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
PTCHD2 sgRNA CRISPR Lentivector set (Human) |
K1748901 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Canine C-Peptide ELISA Kit |
DLR-C-Peptide-c-48T |
DL Develop |
48T |
EUR 632.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine C-Peptide ELISA Kit |
DLR-C-Peptide-c-96T |
DL Develop |
96T |
EUR 825.6 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human C-Peptide ELISA Kit |
DLR-C-Peptide-Hu-48T |
DL Develop |
48T |
EUR 477.6 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human C-Peptide ELISA Kit |
DLR-C-Peptide-Hu-96T |
DL Develop |
96T |
EUR 613.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse C-Peptide ELISA Kit |
DLR-C-Peptide-Mu-48T |
DL Develop |
48T |
EUR 540 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse C-Peptide ELISA Kit |
DLR-C-Peptide-Mu-96T |
DL Develop |
96T |
EUR 698.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat C-Peptide ELISA Kit |
DLR-C-Peptide-Ra-48T |
DL Develop |
48T |
EUR 560.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat C-Peptide ELISA Kit |
DLR-C-Peptide-Ra-96T |
DL Develop |
96T |
EUR 726 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine C-Peptide ELISA Kit |
RDR-C-Peptide-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 668.4 |
Canine C-Peptide ELISA Kit |
RDR-C-Peptide-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 928.8 |
Human C-Peptide ELISA Kit |
RDR-C-Peptide-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 484.8 |
Human C-Peptide ELISA Kit |
RDR-C-Peptide-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 667.2 |
Mouse C-Peptide ELISA Kit |
RDR-C-Peptide-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 558 |
Mouse C-Peptide ELISA Kit |
RDR-C-Peptide-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 771.6 |
Rat C-Peptide ELISA Kit |
RDR-C-Peptide-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 583.2 |
Rat C-Peptide ELISA Kit |
RDR-C-Peptide-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 806.4 |
Canine C-Peptide ELISA Kit |
RD-C-Peptide-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 639.6 |
Canine C-Peptide ELISA Kit |
RD-C-Peptide-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 888 |
Human C-Peptide ELISA Kit |
RD-C-Peptide-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 464.4 |
Human C-Peptide ELISA Kit |
RD-C-Peptide-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 638.4 |
Mouse C-Peptide ELISA Kit |
RD-C-Peptide-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 535.2 |
Mouse C-Peptide ELISA Kit |
RD-C-Peptide-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 738 |
Rat C-Peptide ELISA Kit |
RD-C-Peptide-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 558 |
Rat C-Peptide ELISA Kit |
RD-C-Peptide-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 771.6 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3185202 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3185203 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3185204 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1748902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1748903 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1748904 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 Protein Vector (Human) (pPB-C-His) |
PV114046 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPB-N-His) |
PV114047 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPM-C-HA) |
PV114048 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPM-C-His) |
PV114049 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Mouse) (pPB-C-His) |
PV220606 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Mouse) (pPB-N-His) |
PV220607 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Mouse) (pPM-C-HA) |
PV220608 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Mouse) (pPM-C-His) |
PV220609 |
ABM |
500 ng |
EUR 2766 |
Ptchd2 3'UTR GFP Stable Cell Line |
TU167223 |
ABM |
1.0 ml |
Ask for price |
Ptchd2 3'UTR Luciferase Stable Cell Line |
TU117223 |
ABM |
1.0 ml |
Ask for price |
PTCHD2 3'UTR GFP Stable Cell Line |
TU069132 |
ABM |
1.0 ml |
EUR 1672.8 |
PTCHD2 3'UTR Luciferase Stable Cell Line |
TU019132 |
ABM |
1.0 ml |
EUR 1672.8 |
Mouse Patched domain- containing protein 2, Ptchd2 ELISA KIT |
ELI-43078m |
Lifescience Market |
96 Tests |
EUR 1038 |
Human Patched domain- containing protein 2, PTCHD2 ELISA KIT |
ELI-44851h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3185205 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K1748905 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3185206 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3185207 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3185208 |
ABM |
1.0 ug DNA |
EUR 200.4 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K1748906 |
ABM |
1.0 ug DNA |
EUR 200.4 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K1748907 |
ABM |
1.0 ug DNA |
EUR 200.4 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K1748908 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Human Connecting Peptide (C-Peptide) Peptide |
abx670072-05mg |
Abbexa |
0.5 mg |
EUR 678 |
|
TKD Peptide (Hsp70 Peptide) (Hsp70 Peptide) |
SIH-118A |
Stressmarq |
1 mg |
EUR 374.4 |
|
Description: The substance TKD Peptide (Hsp70 Peptide) is a hsp70 peptide. It is synthetically produced and has a purity of >98%. The pure substance is solid which is In aqueous solution. |
Rat Connecting Peptide (C-Peptide) Peptide (OVA) |
20-abx651058 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1378.80
-
EUR 594.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
TKD Peptide (Hsp70 Peptide): FITC (Hsp70 Peptide) |
SIH-119A |
Stressmarq |
1 mg |
EUR 430.8 |
|
Description: The substance TKD Peptide (Hsp70 Peptide): FITC is a hsp70 peptide. It is synthetically produced and has a purity of >98%. The pure substance is solid which is In aqueous solution. |
TKD Peptide (Hsp70 Peptide) |
abx076809-1mg |
Abbexa |
1 mg |
EUR 594 |
|
C-Peptide Blocking Peptide |
3277BP-50 |
Biovision |
each |
EUR 183.6 |
Connecting Peptide (C-Peptide) Antibody |
20-abx100155 |
Abbexa |
-
EUR 309.60
-
EUR 159.60
-
EUR 727.20
-
EUR 393.60
-
EUR 276.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
TKD Peptide (Hsp70 Peptide) (FITC) |
abx076810-1mg |
Abbexa |
1 mg |
EUR 678 |
|
Human Peptide YY (PYY) Peptide |
20-abx068451 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Peptide YY (PYY) Peptide |
20-abx068452 |
Abbexa |
-
EUR 710.40
-
EUR 309.60
-
EUR 2131.20
-
EUR 844.80
-
EUR 526.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Peptide YY (PYY) Peptide |
20-abx068453 |
Abbexa |
-
EUR 744.00
-
EUR 326.40
-
EUR 2230.80
-
EUR 878.40
-
EUR 543.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Connecting Peptide (C-Peptide) Antibody |
abx021134-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Connecting Peptide (C-Peptide) Antibody |
abx021135-1mg |
Abbexa |
1 mg |
EUR 886.8 |
|
Connecting Peptide (C-Peptide) Antibody |
abx022864-01ml |
Abbexa |
0.1 ml |
EUR 693.6 |
|
Connecting Peptide (C-peptide) Antibody |
abx023812-1mg |
Abbexa |
1 mg |
EUR 886.8 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414631-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414632-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414633-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414789-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414790-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Connecting Peptide (C-Peptide) Antibody |
abx411178-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
Formyl Peptide Receptor-like 2 Peptide |
43-293P |
ProSci |
0.1 mg |
EUR 405.6 |
Human Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069654 |
Abbexa |
-
EUR 794.40
-
EUR 326.40
-
EUR 2448.00
-
EUR 944.40
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069655 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2548.80
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069656 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2598.00
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Glutaminyl Peptide Cyclotransferase (QPCT) Peptide |
20-abx168154 |
Abbexa |
-
EUR 794.40
-
EUR 326.40
-
EUR 2448.00
-
EUR 944.40
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Cow Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx166274 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2331.60
-
EUR 910.80
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Cow Atrial Natriuretic Peptide (ANP) Peptide |
20-abx166288 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Connecting Peptide (C-Peptide) Antibody (Biotin) |
abx021132-100ug |
Abbexa |
100 ug |
EUR 693.6 |
|
Mouse Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065482 |
Abbexa |
-
EUR 811.20
-
EUR 343.20
-
EUR 2498.40
-
EUR 961.20
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065483 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065484 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2331.60
-
EUR 910.80
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065486 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2331.60
-
EUR 910.80
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Dog Brain Natriuretic Peptide (BNP) Peptide |
20-abx065598 |
Abbexa |
-
EUR 1062.00
-
EUR 393.60
-
EUR 3400.80
-
EUR 1262.40
-
EUR 727.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Brain Natriuretic Peptide (BNP) Peptide |
20-abx065599 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Brain Natriuretic Peptide (BNP) Peptide |
20-abx065600 |
Abbexa |
-
EUR 895.20
-
EUR 360.00
-
EUR 2798.40
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Pig Brain Natriuretic Peptide (BNP) Peptide |
20-abx065601 |
Abbexa |
-
EUR 994.80
-
EUR 376.80
-
EUR 3199.20
-
EUR 1195.20
-
EUR 693.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Brain Natriuretic Peptide (BNP) Peptide |
20-abx065602 |
Abbexa |
-
EUR 895.20
-
EUR 360.00
-
EUR 2798.40
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Cathelicidin Antimicrobial Peptide (CAMP) Peptide |
20-abx065799 |
Abbexa |
-
EUR 927.60
-
EUR 360.00
-
EUR 2932.80
-
EUR 1111.20
-
EUR 661.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Cathelicidin Antimicrobial Peptide (CAMP) Peptide |
20-abx065800 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2581.20
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Cathelicidin Antimicrobial Peptide (CAMP) Peptide |
20-abx065801 |
Abbexa |
-
EUR 895.20
-
EUR 343.20
-
EUR 2781.60
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Galanin Like Peptide (GALP) Peptide |
20-abx650475 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2364.00
-
EUR 927.60
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Brain natriuretic peptide (BNP) Peptide |
abx670010-01mg |
Abbexa |
0.1 mg |
EUR 360 |
|
Vasoactive Intestinal Peptide (VIP) Peptide (OVA) |
20-abx651057 |
Abbexa |
-
EUR 493.20
-
EUR 260.40
-
EUR 1296.00
-
EUR 560.40
-
EUR 360.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Dog Peptide YY (PYY) Peptide (OVA) |
20-abx651198 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1178.40
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Peptide YY (PYY) Peptide (OVA) |
20-abx651199 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1178.40
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Pig Peptide YY (PYY) Peptide (OVA) |
20-abx651200 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1178.40
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Peptide YY (PYY) Peptide (OVA) |
20-abx651201 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1178.40
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human C-Peptide (CP) Peptide (OVA) |
20-abx651801 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Peptide YY (PYY) Peptide (OVA) |
20-abx651848 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Atrial Natriuretic Peptide (ANP) Peptide |
20-abx652084 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Brain Natriuretic Peptide (BNP) Peptide |
20-abx652109 |
Abbexa |
-
EUR 910.80
-
EUR 360.00
-
EUR 2865.60
-
EUR 1095.60
-
EUR 644.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx652275 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Osteogenic Growth Peptide (OGP) Peptide |
20-abx652290 |
Abbexa |
-
EUR 661.20
-
EUR 292.80
-
EUR 1914.00
-
EUR 777.60
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
DDK Peptide |
D4503-004 |
GenDepot |
4mg |
EUR 327.6 |
DDK Peptide |
D4503-025 |
GenDepot |
25mg |
EUR 1161.6 |
SIK2 Peptide |
6301P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SIK2 peptide |
SPT1 Peptide |
6303P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SPT1 peptide |
SPT2 Peptide |
6305P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SPT2 peptide |
IRF4 Peptide |
6307P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) IRF4 peptide |
MSI2 Peptide |
6309P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) MSI2 peptide |
NUMB Peptide |
6311P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) NUMB peptide |
ORMDL1 Peptide |
6313P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) ORMDL1 peptide |
SGK1 Peptide |
6319P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SGK1 peptide |
VASH1 Peptide |
6325P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) VASH1 peptide |
Anosmin Peptide |
6367P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) Anosmin peptide |
Translin Peptide |
6369P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) Translin peptide |
RASSF10 Peptide |
6371P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) RASSF10 peptide |
TYW1 Peptide |
6373P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) TYW1 peptide |
TYW2 Peptide |
6375P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) TYW2 peptide |
TYW3 Peptide |
6377P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) TYW3 peptide |
TYW4 Peptide |
6379P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) TYW4 peptide |
MEIG1 Peptide |
6381P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) MEIG1 peptide |
TEKT5 Peptide |
6383P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) TEKT5 peptide |
GEMC1 Peptide |
6385P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) GEMC1 peptide |
ATAD3A Peptide |
6387P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) ATAD3A peptide |
ATAD3B Peptide |
6389P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) ATAD3B peptide |
AP3S1 Peptide |
6391P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) AP3S1 peptide |
AP3M1 Peptide |
6393P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) AP3M1 peptide |
AP3B2 Peptide |
6395P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) AP3B2 peptide |
TMEM88 Peptide |
6397P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) TMEM88 peptide |
CCDC141 Peptide |
6399P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) CCDC141 peptide |
SPRYD2 Peptide |
6403P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SPRYD2 peptide |
SPRYD3 Peptide |
6405P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SPRYD3 peptide |
SPRYD4 Peptide |
6407P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SPRYD4 peptide |
SPRYD5 Peptide |
6409P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SPRYD5 peptide |
HDGFRP2 Peptide |
6411P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) HDGFRP2 peptide |
SYTL5 Peptide |
6413P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) SYTL5 peptide |
TMEM204 Peptide |
6415P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) TMEM204 peptide |
KCNK13 Peptide |
6423P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) KCNK13 peptide |
KCNK12 Peptide |
6425P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) KCNK12 peptide |
TMEM59L Peptide |
6435P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) TMEM59L peptide |
LY6K Peptide |
6437P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) LY6K peptide |
L1TD1 Peptide |
6439P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) L1TD1 peptide |
CHD7 Peptide |
6441P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) CHD7 peptide |
EIG121 Peptide |
6443P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) EIG121 peptide |
ARHGAP39 Peptide |
6445P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) ARHGAP39 peptide |
IFTLD1 Peptide |
6447P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) IFTLD1 peptide |
Paralemmin3 Peptide |
6449P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) Paralemmin3 peptide |
TMEM147 Peptide |
6453P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) TMEM147 peptide |
DBX1 Peptide |
6455P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) DBX1 peptide |
UHRF1BP1 Peptide |
6459P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) UHRF1BP1 peptide |
UHRF1BP1L Peptide |
6461P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) UHRF1BP1L peptide |
FXYD7 Peptide |
6465P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) FXYD7 peptide |
NETO1 Peptide |
6469P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) NETO1 peptide |
SEC62 Peptide |
6471P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) SEC62 peptide |
DDA Peptide |
6483P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) DDA peptide |
DPAGT1 Peptide |
6485P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) DPAGT1 peptide |
EI24 Peptide |
6487P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) EI24 peptide |
HIG1 Peptide |
6489P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) HIG1 peptide |
HIG2 Peptide |
6491P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) HIG2 peptide |
Even though we only observed the PP association with anxiety and age with NPY and PP in men, suggesting the possibility of the effect of sex hormones on the NPY system. However, an increase in anxiety scores does not lead to significant changes in NPY.